167 related articles for article (PubMed ID: 30442364)
21. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
[TBL] [Abstract][Full Text] [Related]
22. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
23. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
24. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
[TBL] [Abstract][Full Text] [Related]
25. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
26. Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients.
González-Vallinas M; Rodríguez-Paredes M; Albrecht M; Sticht C; Stichel D; Gutekunst J; Pitea A; Sass S; Sánchez-Rivera FJ; Lorenzo-Bermejo J; Schmitt J; De La Torre C; Warth A; Theis FJ; Müller NS; Gretz N; Muley T; Meister M; Tschaharganeh DF; Schirmacher P; Matthäus F; Breuhahn K
Mol Cancer Res; 2018 Mar; 16(3):390-402. PubMed ID: 29330288
[TBL] [Abstract][Full Text] [Related]
27. Identification of microRNAs as potential prognostic markers in ependymoma.
Costa FF; Bischof JM; Vanin EF; Lulla RR; Wang M; Sredni ST; Rajaram V; Bonaldo Mde F; Wang D; Goldman S; Tomita T; Soares MB
PLoS One; 2011; 6(10):e25114. PubMed ID: 22053178
[TBL] [Abstract][Full Text] [Related]
28. Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas.
Sandhu V; Bowitz Lothe IM; Labori KJ; Lingjærde OC; Buanes T; Dalsgaard AM; Skrede ML; Hamfjord J; Haaland T; Eide TJ; Børresen-Dale AL; Ikdahl T; Kure EH
Mol Oncol; 2015 Apr; 9(4):758-71. PubMed ID: 25579086
[TBL] [Abstract][Full Text] [Related]
29. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study.
Kim JE; Eom JS; Kim WY; Jo EJ; Mok J; Lee K; Kim KU; Park HK; Lee MK; Kim MH
Thorac Cancer; 2018 Aug; 9(8):911-915. PubMed ID: 29806739
[TBL] [Abstract][Full Text] [Related]
31. Potential Five-MicroRNA Signature Model for the Prediction of Prognosis in Patients with Wilms Tumor.
Gong Y; Zou B; Chen J; Ding L; Li P; Chen J; Chen J; Zhang B; Li J
Med Sci Monit; 2019 Jul; 25():5435-5444. PubMed ID: 31328722
[TBL] [Abstract][Full Text] [Related]
32. A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
Xu M; Kuang Y; Wang M; Han X; Yang Q
Neoplasma; 2017; 64(1):56-64. PubMed ID: 27881005
[TBL] [Abstract][Full Text] [Related]
33. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY
Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.
He SY; Xi WJ; Wang X; Xu CH; Cheng L; Liu SY; Meng QQ; Li B; Wang Y; Shi HB; Wang HJ; Wang ZZ
Med Sci Monit; 2019 May; 25():3941-3956. PubMed ID: 31132294
[TBL] [Abstract][Full Text] [Related]
35. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
[TBL] [Abstract][Full Text] [Related]
38. miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
Takashima Y; Kawaguchi A; Iwadate Y; Hondoh H; Fukai J; Kajiwara K; Hayano A; Yamanaka R
PLoS One; 2020; 15(2):e0229577. PubMed ID: 32101576
[TBL] [Abstract][Full Text] [Related]
39. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
[TBL] [Abstract][Full Text] [Related]
40. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
Liu H; Liu L; Zhu H
J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]